Can These Compounds Protect Against the Toxic Effects of Asbestos?
A recent study out of Australia suggests that compounds called zeolites might offer protection against the toxic effects of asbestos. Asbestos is the primary cause of malignant mesothelioma. Mesothelioma is a rare and aggressive cancer for which there is no cure. There is no way to remove asbestos from the body after a person has been exposed. But the new study suggests that zeolites might counteract some of the toxic effects of asbestos. If the impact can be validated in humans, it could one day change the outcomes for thousands of people at risk for mesothelioma. What Are the Toxic Effects of Asbestos? Asbestos is a naturally-occurring mineral made up of long microscopic fibers. The size and shape of these … Continue reading Can These Compounds Protect Against the Toxic Effects of Asbestos?
Asbestos and Lung Cancer: Study Highlights the Link
A new report on asbestos and lung cancer says asbestos could be to blame for the cancer, even if the patient is a heavy smoker. In smokers, lung cancer is usually attributed to tobacco use. But cancer researchers in Australia and Finland say that is not always right, especially if the patient has been exposed to asbestos. They propose new criteria for establishing the cause of lung cancer in asbestos-exposed people. The criteria would apply to both smokers and non-smokers. Mesothelioma is Not the Only Cancer Linked to Exposure Malignant mesothelioma is the cancer most often associated with asbestos exposure. Mesothelioma is a rare but fast-growing and treatment-resistant cancer. Asbestos exposure is the only known cause of mesothelioma. Smoking increases … Continue reading Asbestos and Lung Cancer: Study Highlights the Link
History of Asbestos Mining Blamed for Mesothelioma Epidemic
Residents of Western Australia are still paying the price for the history of asbestos mining in the region. A new report from the University of Western Australia focuses on people in the region of the now-closed Wittenoom asbestos mine. The report blames the mine and its products for an “ongoing epidemic of mortality from lung cancer and malignant mesothelioma”. Australia’s Sad History of Asbestos Mining Asbestos is a mineral once prized for its strength and abundance. It was used around the world in thousands of products, including many construction materials. Australia has a long history of asbestos mining and exportation. The country was once one of the world’s top producers of asbestos. The Australian Blue Asbestos Company in Wittenoom was … Continue reading History of Asbestos Mining Blamed for Mesothelioma Epidemic
Signs of Peritoneal Mesothelioma After Radiotherapy
Japanese researchers are reminding doctors to watch for signs of peritoneal mesothelioma in people who have undergone past radiotherapy. Many cancer patients undergo radiotherapy. Radiation disrupts the DNA inside cancer cells. This can help keep these malignant cells from replicating and spreading. But radiation treatment also has a downside. It can cause cellular changes in healthy cells, too. This can cause side effects right away, or decades later. As more people have radiation and survive, scientists at the Shinshu University School of Medicine say more of them could develop radiation-related mesothelioma later in life. But the signs of peritoneal mesothelioma years after radiation are easy to miss. Peritoneal Mesothelioma Case Study The new report is based on the case of … Continue reading Signs of Peritoneal Mesothelioma After Radiotherapy
MicroRNA Signature for Mesothelioma Could Lead to Earlier Diagnosis
Australian researchers believe they have identified what amounts to a microRNA signature for mesothelioma in pleural effusion. Pleural effusion is the name for excess lung fluid. Up to 90 percent of pleural mesothelioma patients develop a pleural effusion. Researchers at the University of Western Australia say this fluid contains a wealth of information that could improve mesothelioma diagnosis. They have recently identified a trio of RNA molecules in fluid samples that could serve as a microRNA signature for mesothelioma. This “signature” could help doctors distinguish mesothelioma from other types of cancer. The Challenge of Mesothelioma Diagnosis Pleural mesothelioma is notoriously hard to diagnose. The early symptoms of mesothelioma are similar to the symptoms of many other lung conditions. They are … Continue reading MicroRNA Signature for Mesothelioma Could Lead to Earlier Diagnosis
Mesothelioma Risk From Home Renovation in The Spotlight
The case of an Australian man is highlighting the mesothelioma risk from home renovation when asbestos is present. Forty-two year old Matthew Werfel recently won a lawsuit against Amaca, the asbestos producer previously known as James Hardie. The company manufactured the asbestos-containing cement sheets that led to Werfel’s pleural mesothelioma. The record $3 million payout is an expensive warning to other DIY homeowners about the potential mesothelioma risk from home renovation. Asbestos in Construction Products Asbestos is a mineral that has to be mined from the ground. As early as the 1930’s, companies like James Hardie recognized its potential value as a construction material. Asbestos is strong, plentiful and resistant to heat and corrosion. It was used for decades to … Continue reading Mesothelioma Risk From Home Renovation in The Spotlight
Large Study Finds Treatment Combination Leads to Long-Term Mesothelioma Survival
There is more evidence that surgery and intraperitoneal chemotherapy can lead to long-term mesothelioma survival. The news comes from an Australian study of more than 1,200 cancer patients. The study finds that one in five peritoneal mesothelioma patients who had this treatment combination were still alive 10 years later. Peritoneal Cancer Survival with Surgery Peritoneal cancers occur on the lining of the abdomen. Peritoneal mesothelioma starts on this peritoneal membrane. Some other peritoneal cancers start elsewhere in the body and spread to the peritoneum. The new Australian study analyzed the cases of peritoneal cancer patients who had cytoreductive surgery between 1996 and 2018. Cytoreductive surgery aims to remove as much of the cancer as possible. Past studies have found that … Continue reading Large Study Finds Treatment Combination Leads to Long-Term Mesothelioma Survival
Minimally Invasive Mesothelioma Diagnosis from Lung Fluid
Minimally invasive mesothelioma diagnosis with lung fluid may be just as effective as a tissue biopsy. That’s according to Australian mesothelioma researchers. Australia was once one of the biggest producers of asbestos and now has some of the highest mesothelioma rates in the world. It is also home to high-level mesothelioma research. In the latest study, scientists ran a meta-analysis comparing surgical biopsy with a minimally invasive mesothelioma diagnosis tool called cytology. Their conclusion is that surgery may not always be necessary to diagnose malignant mesothelioma. Tissue Versus Lung Fluid Malignant mesothelioma is a fatal cancer caused by exposure to asbestos. It is challenging to diagnose because the symptoms are often vague and similar to other less serious conditions. Doctors … Continue reading Minimally Invasive Mesothelioma Diagnosis from Lung Fluid
Chemoimmunotherapy Called “Next Frontier” for Mesothelioma Cancer
Mesothelioma researchers in Australia are calling the combination of chemotherapy and immunotherapy the “next frontier” in the treatment of mesothelioma cancer. In a study published in the journal Expert Opinions in Biological Therapy, the researchers reviewed past clinical trials on mesothelioma immunotherapy. They focused on studies published between 2016 and 2018. Their goal was to get a clearer picture of just how effective these drugs are and how they might be used in combination with other treatments. Chemotherapy for Mesothelioma Cancer Currently, immunotherapy is not the primary treatment for mesothelioma cancer. Instead, most patients have chemotherapy, which is considered the gold standard treatment. For the past 15 years, Alimta has been the main chemotherapy drug for people with malignant mesothelioma. … Continue reading Chemoimmunotherapy Called “Next Frontier” for Mesothelioma Cancer
Study Reveals Mesothelioma Chemotherapy May Be Underused in Older Patients
The older a mesothelioma patient is, the less likely he or she may be to receive mesothelioma chemotherapy. A new study says many older mesothelioma sufferers may be paying the price in shorter lifespans. Chemotherapy with pemetrexed (Alimta) and cisplatin is the gold standard for mesothelioma treatment. Many studies have linked it with longer mesothelioma survival. But an Australian study suggests that not enough older people are receiving mesothelioma chemotherapy. In fact, the older they are, the less likely they are to have chemotherapy for their mesothelioma. As a result, their chances of dying from malignant mesothelioma are higher. Mesothelioma Chemotherapy is Standard of Care Malignant mesothelioma is a hard-to-treat cancer with a poor prognosis. Mesothelioma chemotherapy is the primary … Continue reading Study Reveals Mesothelioma Chemotherapy May Be Underused in Older Patients
“My Name is Paul Kraus and I Have Survived Mesothelioma for Over 20 Years.”
In 1997 I was diagnosed with mesothelioma. The doctors gave me just a few short months to live...
But here I am, 20 years later, alive and well.
I wrote a book explaining how I became the longest living mesothelioma survivor in the world.
Today, I'd like to give you a copy for free because I want more people to survive this disease.
All you have to do is click the button below now. You will receive the book within 72 hours.
I wish you good health.
Sincerely,
"It has been over four years now and I can honestly say I am doing great. I highly recommend this book because it is inspirational and educational."
Get your free copy of
“Surviving Mesothelioma” Today!